Algorithm for Management of Acute Kidney Injury (AKI) - Flowchart
Algorithm for Management of Acute Kidney Injury (AKI) - Flowchart Acute Kidney injury Acute Kidney injury
«Flowchart»

Acute kidney injury

Acute kidney injury

Acute kidney injury

Acute kidney injury

Prerenal (prerenal azotemia, HRS)

Prerenal (prerenal azotemia, HRS)

Prerenal (prerenal azotemia, HRS)

Renal (GN, ATN, AIN)

Renal (GN, ATN, AIN)

Renal (GN, ATN, AIN)

Postrenal (BPH)

Postrenal (BPH)

Postrenal (BPH)

End

End

End


Postvoid residual
Foley placement
Renal ultrasound
Bladder pressure
Paracentesis for tense ascites


Postvoid residual
Foley placement
Renal ultrasound
Bladder pressure
Paracentesis for tense ascites


Postvoid residual
Foley placement
Renal ultrasound
Bladder pressure
Paracentesis for tense ascites


Postvoid residual
Foley placement
Renal ultrasound
Bladder pressure
Paracentesis for tense ascites


Discontinue nephrotoxins
Workup sepsis


Discontinue nephrotoxins
Workup sepsis


Discontinue nephrotoxins
Workup sepsis


Discontinue nephrotoxins
Workup sepsis


Discontinue diuretics
Workup sepsis


Discontinue diuretics
Workup sepsis


Discontinue diuretics
Workup sepsis


Discontinue diuretics
Workup sepsis


No volume expansion
Confirmatory tests
Specific therapy


No volume expansion
Confirmatory tests
Specific therapy


No volume expansion
Confirmatory tests
Specific therapy


No volume expansion
Confirmatory tests
Specific therapy

Clinically volume depleted (over diuresis, diarrhea)

Clinically volume depleted (over diuresis, diarrhea)

Clinically volume depleted

No obviously volume depleted

No obviously volume depleted

No obviously volume depleted

Crystalloid and/or 5% albumin

Crystalloid and/or 5% albumin

Crystalloid and/or 5% albumin

25% albumin 1 g/kg in first 24 hr (≤100 g)

25% albumin 1 g/kg in first 24 hr (≤100 g)

25% albumin 1 g/kg in first 24 hr (≤100 g)

≤

Surveillance

Surveillance

Surveillance

Hepatorenal syndrome

Hepatorenal syndrome

Hepatorenal syndrome

ATN

ATN

ATN

Consider renal replacement therapy

Consider renal replacement therapy

Consider renal replacement therapy

Stop therapy after complete response for a maximum of 14 days or development of complication

Stop therapy after complete response for a maximum of 14 days or development of complication

Stop therapy after complete response for a maximum of 14 days or development of complication

Assess AKI evaluation at 48 hr

Assess AKI evaluation at 48 hr

Assess AKI evaluation at 48 hr

Resolution

Resolution

Resolution

Persistence/progression

Persistence/progression

Persistence/progression

Vasoconstrictor + albumin

Vasoconstrictor + albumin

Vasoconstrictor + albumin

No improvement in kidney function

No improvement in kidney function

No improvement

Improvement in kidney function

Improvement in kidney function

Improvement